A Study of LY3023414 in Participants With Advanced Cancer

Clinical trial NCT01655225 · COMPLETED

Trial details

NCT number: NCT01655225
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Metastatic Cancer Non-Hodgkin's Lymphoma Metastatic Breast Cancer Malignant Mesothelioma Non-small Cell Lung Cancer

Start date: 2012-07-31
Primary completion: 2019-04-04
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.